Sanofi Pasteur initiates Phase III Study of Investigational Clostridium Difficile Vaccine
Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases ...
Tuesday, October 6, 2026
ADVERTISEMENT
Tag: Clostridium Difficile Vaccine
FasterCapital backs a rice production project through EquityPilot
FasterCapital has added a rice production and processing startup to EquityPilot, the firm’s execution-focused program designed to help early-stage ventures...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.